BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krishna BA, Humby MS, Miller WE, O'Connor CM. Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos. Proc Natl Acad Sci U S A 2019;116:1755-64. [PMID: 30647114 DOI: 10.1073/pnas.1816933116] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Wass AB, Krishna BA, Herring LE, Gilbert TSK, Nukui M, Groves IJ, Dooley AL, Kulp KH, Matthews SM, Rotroff DM, Graves LM, O’connor CM. Cytomegalovirus US28 regulates cellular EphA2 to maintain viral latency. Sci Adv 2022;8. [DOI: 10.1126/sciadv.add1168] [Reference Citation Analysis]
2 Krishna BA, Wass AB, Murphy EA, O'Connor CM. Design of a US28 ORF Deletion Virus in a Temperature-Sensitive Cytomegalovirus Strain Fails to Promote Lytic Replication in Hematopoietic Cells. Viruses 2022;14:1280. [PMID: 35746751 DOI: 10.3390/v14061280] [Reference Citation Analysis]
3 Bergkamp ND, Siderius M, Smit MJ. Pharmacology of Viral GPCRs: All-Round Chemokine Receptor Homologs. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00203-6] [Reference Citation Analysis]
4 Smith NA, Chan GC, O'Connor CM. Modulation of host cell signaling during cytomegalovirus latency and reactivation. Virol J 2021;18:207. [PMID: 34663377 DOI: 10.1186/s12985-021-01674-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Elder EG, Krishna BA, Poole E, Perera M, Sinclair J. Regulation of host and viral promoters during human cytomegalovirus latency via US28 and CTCF. J Gen Virol 2021;102. [PMID: 34042564 DOI: 10.1099/jgv.0.001609] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
6 De Groof TWM, Elder EG, Lim EY, Heukers R, Bergkamp ND, Groves IJ, Wills M, Sinclair JH, Smit MJ. Targeting the latent human cytomegalovirus reservoir for T-cell-mediated killing with virus-specific nanobodies. Nat Commun 2021;12:4436. [PMID: 34290252 DOI: 10.1038/s41467-021-24608-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
7 Sausen DG, Reed KM, Bhutta MS, Gallo ES, Borenstein R. Evasion of the Host Immune Response by Betaherpesviruses. Int J Mol Sci 2021;22:7503. [PMID: 34299120 DOI: 10.3390/ijms22147503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
8 Poole EL, Nevels MM. Editorial: Cytomegalovirus Pathogenesis and Host Interactions. Front Cell Infect Microbiol 2021;11:711551. [PMID: 34307201 DOI: 10.3389/fcimb.2021.711551] [Reference Citation Analysis]
9 Jackson SE, Chen KC, Groves IJ, Sedikides GX, Gandhi A, Houldcroft CJ, Poole EL, Montanuy I, Mason GM, Okecha G, Reeves MB, Sinclair JH, Wills MR. Latent Cytomegalovirus-Driven Recruitment of Activated CD4+ T Cells Promotes Virus Reactivation. Front Immunol 2021;12:657945. [PMID: 33912186 DOI: 10.3389/fimmu.2021.657945] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 De Groof TWM, Elder EG, Siderius M, Heukers R, Sinclair JH, Smit MJ. Viral G Protein-Coupled Receptors: Attractive Targets for Herpesvirus-Associated Diseases. Pharmacol Rev 2021;73:828-46. [PMID: 33692148 DOI: 10.1124/pharmrev.120.000186] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
11 Krishna BA, Wass AB, Dooley AL, O'Connor CM. CMV-encoded GPCR pUL33 activates CREB and facilitates its recruitment to the MIE locus for efficient viral reactivation. J Cell Sci 2021;134:jcs254268. [PMID: 33199520 DOI: 10.1242/jcs.254268] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Mason R, Groves IJ, Wills MR, Sinclair JH, Reeves MB. Human cytomegalovirus major immediate early transcripts arise predominantly from the canonical major immediate early promoter in reactivating progenitor-derived dendritic cells. J Gen Virol 2020;101:635-44. [PMID: 32375946 DOI: 10.1099/jgv.0.001419] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
13 Dooley AL, O'Connor CM. Regulation of the MIE Locus During HCMV Latency and Reactivation. Pathogens 2020;9:E869. [PMID: 33113934 DOI: 10.3390/pathogens9110869] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
14 Vasilieva E, Gianella S, Freeman ML. Novel Strategies to Combat CMV-Related Cardiovascular Disease. Pathog Immun 2020;5:240-74. [PMID: 33089035 DOI: 10.20411/pai.v5i1.382] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
15 Collins-McMillen D, Kamil J, Moorman N, Goodrum F. Control of Immediate Early Gene Expression for Human Cytomegalovirus Reactivation. Front Cell Infect Microbiol 2020;10:476. [PMID: 33072616 DOI: 10.3389/fcimb.2020.00476] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
16 Krishna BA, Wass AB, O'Connor CM. Activator protein-1 transactivation of the major immediate early locus is a determinant of cytomegalovirus reactivation from latency. Proc Natl Acad Sci U S A 2020;117:20860-7. [PMID: 32788362 DOI: 10.1073/pnas.2009420117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
17 Hancock MH, Mitchell J, Goodrum FD, Nelson JA. Human Cytomegalovirus miR-US5-2 Downregulation of GAB1 Regulates Cellular Proliferation and UL138 Expression through Modulation of Epidermal Growth Factor Receptor Signaling Pathways. mSphere 2020;5:e00582-20. [PMID: 32759334 DOI: 10.1128/mSphere.00582-20] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
18 Min CK, Shakya AK, Lee BJ, Streblow DN, Caposio P, Yurochko AD. The Differentiation of Human Cytomegalovirus Infected-Monocytes Is Required for Viral Replication. Front Cell Infect Microbiol 2020;10:368. [PMID: 32850474 DOI: 10.3389/fcimb.2020.00368] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
19 Mlera L, Moy M, Maness K, Tran LN, Goodrum FD. The Role of the Human Cytomegalovirus UL133-UL138 Gene Locus in Latency and Reactivation. Viruses 2020;12:E714. [PMID: 32630219 DOI: 10.3390/v12070714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
20 Korbecki J, Simińska D, Kojder K, Grochans S, Gutowska I, Chlubek D, Baranowska-Bosiacka I. Fractalkine/CX3CL1 in Neoplastic Processes. Int J Mol Sci 2020;21:E3723. [PMID: 32466280 DOI: 10.3390/ijms21103723] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
21 De Groof TW, Elder EG, Heukers R, Lim EY, Wills M, Sinclair JH, Smit MJ. Targeting the latent human cytomegalovirus reservoir with virus specific nanobodies.. [DOI: 10.1101/2020.05.12.071860] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Krishna BA, Wass AB, Sridharan R, O'Connor CM. The Requirement for US28 During Cytomegalovirus Latency Is Independent of US27 and US29 Gene Expression. Front Cell Infect Microbiol 2020;10:186. [PMID: 32411622 DOI: 10.3389/fcimb.2020.00186] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
23 van Senten JR, Fan TS, Siderius M, Smit MJ. Viral G protein-coupled receptors as modulators of cancer hallmarks. Pharmacol Res 2020;156:104804. [PMID: 32278040 DOI: 10.1016/j.phrs.2020.104804] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
24 Forte E, Zhang Z, Thorp EB, Hummel M. Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response. Front Cell Infect Microbiol. 2020;10:130. [PMID: 32296651 DOI: 10.3389/fcimb.2020.00130] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 28.5] [Reference Citation Analysis]
25 Barry PA, Deere JD, Yue Y, Chang WWL, Schmidt KA, Wussow F, Chiuppesi F, Diamond DJ, Sparger EE, Walter MR, Hartigan-O'Connor DJ. Cytomegalovirus-vectored vaccines for HIV and other pathogens. AIDS 2020;34:335-49. [PMID: 31634191 DOI: 10.1097/QAD.0000000000002396] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
26 Weidner-Glunde M, Kruminis-Kaszkiel E, Savanagouder M. Herpesviral Latency-Common Themes. Pathogens 2020;9:E125. [PMID: 32075270 DOI: 10.3390/pathogens9020125] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
27 Krishna BA, Wass AB, O’connor CM. Activator protein-1 transactivation of the major immediate early locus is a determinant of cytomegalovirus reactivation from latency.. [DOI: 10.1101/2020.02.06.929281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Krishna BA, Wass AB, Sridharan R, O’connor CM. The Requirement For US28 During Cytomegalovirus Latency Is Independent Of US27 And US29 Gene Expression.. [DOI: 10.1101/2020.01.19.911503] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Perotti M, Perez L. Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV. Viruses 2019;12:E35. [PMID: 31905677 DOI: 10.3390/v12010035] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
30 Elder EG, Krishna BA, Williamson J, Lim EY, Poole E, Sedikides GX, Wills M, O'Connor CM, Lehner PJ, Sinclair J. Interferon-Responsive Genes Are Targeted during the Establishment of Human Cytomegalovirus Latency. mBio 2019;10:e02574-19. [PMID: 31796538 DOI: 10.1128/mBio.02574-19] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
31 Mirzaei H, Khodadad N, Karami C, Pirmoradi R, Khanizadeh S. The AP-1 pathway; A key regulator of cellular transformation modulated by oncogenic viruses. Rev Med Virol 2020;30:e2088. [PMID: 31788897 DOI: 10.1002/rmv.2088] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
32 Elder EG, Krishna BA, Williamson J, Lim EY, Poole E, Sedikides GX, Wills M, O’connor CM, Lehner PJ, Sinclair J. Interferon-responsive genes are targeted during the establishment of human cytomegalovirus latency.. [DOI: 10.1101/791673] [Reference Citation Analysis]
33 Cobbs C. Cytomegalovirus is a tumor-associated virus: armed and dangerous. Curr Opin Virol 2019;39:49-59. [PMID: 31525538 DOI: 10.1016/j.coviro.2019.08.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
34 Collins-McMillen D, Rak M, Buehler JC, Igarashi-Hayes S, Kamil JP, Moorman NJ, Goodrum F. Alternative promoters drive human cytomegalovirus reactivation from latency. Proc Natl Acad Sci U S A 2019;116:17492-7. [PMID: 31409717 DOI: 10.1073/pnas.1900783116] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
35 Dupont L, Du L, Poulter M, Choi S, McIntosh M, Reeves MB. Src family kinase activity drives cytomegalovirus reactivation by recruiting MOZ histone acetyltransferase activity to the viral promoter. J Biol Chem 2019;294:12901-10. [PMID: 31273084 DOI: 10.1074/jbc.RA119.009667] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
36 Frank T, Niemann I, Reichel A, Stamminger T. Emerging roles of cytomegalovirus-encoded G protein-coupled receptors during lytic and latent infection. Med Microbiol Immunol 2019;208:447-56. [PMID: 30900091 DOI: 10.1007/s00430-019-00595-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
37 Elder E, Sinclair J. HCMV latency: what regulates the regulators? Med Microbiol Immunol 2019;208:431-8. [PMID: 30761409 DOI: 10.1007/s00430-019-00581-1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 13.7] [Reference Citation Analysis]